Tag: preclinical
-
In-Body Gene Editing Tested as Sickle Cell Treatment
Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease.
-
CEPI Funding SARS-CoV-2 Variant Vaccines
CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil.
-
Carb-X Funds Vaccine Against Resistant Staph Infections
An international consortium is funding a vaccine to prevent increasingly resistant Staphylococcus aureus infections found in health care facilities.
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.
-
Micro Robotic Neuro Therapy Company Underway
A company designing microscale robotic devices to deliver therapies to the central nervous system began work in public on treatments for brain disorders.
-
Gene-Edited Transplant Organ Company Raises $125M
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation.
-
AI Process Discovers, Tests Fibrosis Drug in 18 Months
A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease.
-
FDA Issues Covid-19 Variant Regulatory Guidance
Food and Drug Administration is updating its regulatory guidance for Covid-19 drugs and diagnostics to cover emerging mutations in the SARS-CoV-2 virus.
-
Engineered Cell Therapy Company Issues $588M IPO
A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.